Oligonucleotide Synthesis Market

Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025

Oligonucleotide Synthesis Market Segmented By Universal Oligonucleotide Synthesis, Custom Oligonucleotide Synthesis Service Type with Academic, Commercial Application

Industry: Healthcare

Published Date: January-2018

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 159

Report ID: PMRREP3296

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. PMR Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Oligonucleotide Synthesis Market View Point

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. North America Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    4.1. Introduction

    4.2. Regional Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

    4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

        4.3.1. U.S.

        4.3.2. Canada

    4.4. Market Size (US$ Mn) Forecast By Country, 2017-2025

        4.4.1. U.S.

        4.4.2. Canada

    4.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        4.5.1. Universal Oligonucleotide Synthesis

        4.5.2. Custom Oligonucleotide Synthesis

    4.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        4.6.1. Universal Oligonucleotide Synthesis

        4.6.2. Custom Oligonucleotide Synthesis

    4.7. Historical Market Size (US$ Mn) By Application, 2012-2016

        4.7.1. Research & Development

        4.7.2. Clinical & Commercial

    4.8. Market Size (US$ Mn) Forecast By Application, 2017-2025

        4.8.1. Research & Development

        4.8.2. Clinical & Commercial

    4.9. Historical Market Size (US$ Mn) By End Users, 2012-2016

        4.9.1. Biopharmaceutical Companies

        4.9.2. Academic & Research Institutes

        4.9.3. Contract Research Organizations

    4.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        4.10.1. Biopharmaceutical Companies

        4.10.2. Academic & Research Institutes

        4.10.3. Contract Research Organizations

    4.11. Market Attractiveness Analysis

        4.11.1. By Country

        4.11.2. By Service Type

        4.11.3. By Application

        4.11.4. By End Users

    4.12. Key Representative Market Participants

    4.13. Market Presence (Intensity Map)

5. Latin America Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    5.1. Introduction

    5.2. Regional Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Trends

    5.3. Historical Market Size (US$ Mn) By Country, 2012-2016

        5.3.1. Brazil

        5.3.2. Mexico

        5.3.3. Rest of Latin America

    5.4. Market Size (US$ Mn) Forecast By Country, 2017-2025

        5.4.1. Brazil

        5.4.2. Mexico

        5.4.3. Rest of Latin America

    5.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        5.5.1. Universal Oligonucleotide Synthesis

        5.5.2. Custom Oligonucleotide Synthesis

    5.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        5.6.1. Universal Oligonucleotide Synthesis

        5.6.2. Custom Oligonucleotide Synthesis

    5.7. Historical Market Size (US$ Mn) By Application, 2012-2016

        5.7.1. Research & Development

        5.7.2. Clinical & Commercial

    5.8. Market Size (US$ Mn) Forecast By Application, 2017-2025

        5.8.1. Research & Development

        5.8.2. Clinical & Commercial

    5.9. Historical Market Size (US$ Mn) By End Users, 2012-2016

        5.9.1. Biopharmaceutical Companies

        5.9.2. Academic & Research Institutes

        5.9.3. Contract Research Organizations

    5.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        5.10.1. Biopharmaceutical Companies

        5.10.2. Academic & Research Institutes

        5.10.3. Contract Research Organizations

    5.11. Market Attractiveness Analysis

        5.11.1. By Country

        5.11.2. By Service Type

        5.11.3. By Application

        5.11.4. By End Users

    5.12. Key Representative Market Participants

    5.13. Market Presence (Intensity Map)

6. Europe Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    6.1. Introduction

    6.2. Regional Market Dynamics

        6.2.1. Drivers

        6.2.2. Restraints

        6.2.3. Trends

    6.3. Historical Market Size (US$ Mn) By Country, 2012-2016

        6.3.1. Germany

        6.3.2. U.K.

        6.3.3. France

        6.3.4. Italy

        6.3.5. Spain

        6.3.6. Poland

        6.3.7. Russia

        6.3.8. Rest of Europe

    6.4. Market Size (US$ Mn) Forecast By Country, 2017-2025

        6.4.1. Germany

        6.4.2. U.K.

        6.4.3. France

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Russia

        6.4.7. Rest of Europe

    6.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        6.5.1. Universal Oligonucleotide Synthesis

        6.5.2. Custom Oligonucleotide Synthesis

    6.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        6.6.1. Universal Oligonucleotide Synthesis

        6.6.2. Custom Oligonucleotide Synthesis

    6.7. Historical Market Size (US$ Mn) By Application, 2012-2016

        6.7.1. Research & Development

        6.7.2. Clinical & Commercial

    6.8. Market Size (US$ Mn) Forecast By Application, 2017-2025

        6.8.1. Research & Development

        6.8.2. Clinical & Commercial

    6.9. Historical Market Size (US$ Mn) By End Users, 2012-2016

        6.9.1. Biopharmaceutical Companies

        6.9.2. Academic & Research Institutes

        6.9.3. Contract Research Organizations

    6.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        6.10.1. Biopharmaceutical Companies

        6.10.2. Academic & Research Institutes

        6.10.3. Contract Research Organizations

    6.11. Market Attractiveness Analysis

        6.11.1. By Country

        6.11.2. By Service Type

        6.11.3. By Application

        6.11.4. By End Users

    6.12. Key Representative Market Participants

    6.13. Market Presence (Intensity Map)

7. Asia Pacific (APAC) Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    7.1. Introduction

    7.2. Regional Market Dynamics

        7.2.1. Drivers

        7.2.2. Restraints

        7.2.3. Trends

    7.3. Historical Market Size (US$ Mn) By Country, 2012-2016

        7.3.1. China

        7.3.2. India

        7.3.3. Japan

        7.3.4. Australia and New Zealand

        7.3.5. Rest of APAC

    7.4. Market Size (US$ Mn) Forecast By Country, 2017-2025

        7.4.1. China

        7.4.2. India

        7.4.3. Japan

        7.4.4. Australia and New Zealand

        7.4.5. Rest of APAC

    7.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        7.5.1. Universal Oligonucleotide Synthesis

        7.5.2. Custom Oligonucleotide Synthesis

    7.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        7.6.1. Universal Oligonucleotide Synthesis

        7.6.2. Custom Oligonucleotide Synthesis

    7.7. Historical Market Size (US$ Mn) By Application, 2012-2016

        7.7.1. Research & Development

        7.7.2. Clinical & Commercial

    7.8. Market Size (US$ Mn) Forecast By Application, 2017-2025

        7.8.1. Research & Development

        7.8.2. Clinical & Commercial

    7.9. Historical Market Size (US$ Mn) By End Users, 2012-2016

        7.9.1. Biopharmaceutical Companies

        7.9.2. Academic & Research Institutes

        7.9.3. Contract Research Organizations

    7.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        7.10.1. Biopharmaceutical Companies

        7.10.2. Academic & Research Institutes

        7.10.3. Contract Research Organizations

    7.11. Market Attractiveness Analysis

        7.11.1. By Country

        7.11.2. By Service Type

        7.11.3. By Application

        7.11.4. By End Users

    7.12. Key Representative Market Participants

    7.13. Market Presence (Intensity Map)

8. Middle East and Africa (MEA) Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    8.1. Introduction

    8.2. Regional Market Dynamics

        8.2.1. Drivers

        8.2.2. Restraints

        8.2.3. Trends

    8.3. Historical Market Size (US$ Mn) By Country, 2012-2016

        8.3.1. GCC Countries

        8.3.2. South Africa

        8.3.3. Rest of MEA

    8.4. Market Size (US$ Mn) Forecast By Country, 2017-2025

        8.4.1. GCC Countries

        8.4.2. South Africa

        8.4.3. Rest of MEA

    8.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        8.5.1. Universal Oligonucleotide Synthesis

        8.5.2. Custom Oligonucleotide Synthesis

    8.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        8.6.1. Universal Oligonucleotide Synthesis

        8.6.2. Custom Oligonucleotide Synthesis

    8.7. Historical Market Size (US$ Mn) By Application, 2012-2016

        8.7.1. Research & Development

        8.7.2. Clinical & Commercial

    8.8. Market Size (US$ Mn) Forecast By Application, 2017-2025

        8.8.1. Research & Development

        8.8.2. Clinical & Commercial

    8.9. Historical Market Size (US$ Mn) By End Users, 2012-2016

        8.9.1. Biopharmaceutical Companies

        8.9.2. Academic & Research Institutes

        8.9.3. Contract Research Organizations

    8.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        8.10.1. Biopharmaceutical Companies

        8.10.2. Academic & Research Institutes

        8.10.3. Contract Research Organizations

    8.11. Market Attractiveness Analysis

        8.11.1. By Country

        8.11.2. By Service Type

        8.11.3. By Application

        8.11.4. By End Users

    8.12. Key Representative Market Participants

    8.13. Market Presence (Intensity Map)

9. Competition Landscape

    9.1. Market Structure

    9.2. Market Share Analysis

    9.3. Competition Dashboard

    9.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

    9.5. Key Players

        9.5.1. Integrated DNA Technologies, Inc.

        9.5.2. GenScript Biotech Corporation

        9.5.3. Eurofins Scientific SE

        9.5.4. Bioneer Corporation

        9.5.5. Kaneka Corporation (Eurogentec)

        9.5.6. Biolegio B.V.

        9.5.7. Eton Bioscience, Inc.

        9.5.8. IBA GmbH

        9.5.9. Quintara Biosciences

        9.5.10. LGC Biosearch Technologies

        9.5.11. Thermo Fisher Scientific, Inc.

        9.5.12. TriLink BioTechnologies, LLC

        9.5.13. TAG Copenhagen A/S

        9.5.14. PolyGen GmbH

        9.5.15. General Electric Co.

        9.5.16. BioAutomation

        9.5.17. Biolytic Lab Performance Inc.

10. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Region

    10.1. Introduction

        10.1.1. Basis Point Share (BPS) Analysis By Region

        10.1.2. Y-o-Y Growth Projections By Region

    10.2. Historical Market Size Analysis 2012–2016, By Region

        10.2.1. North America

        10.2.2. Latin America

        10.2.3. Europe

        10.2.4. Asia Pacific (APAC)

        10.2.5. Middle East and Africa (MEA)

    10.3. Market Size Analysis 2017–2015, By Region

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific (APAC)

        10.3.5. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Service Type

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Service Type

        11.1.2. Y-o-Y Growth Projections By Service Type

    11.2. Historical Market Size (US$ Mn) By Service Type, 2012-2016

        11.2.1. Universal Oligonucleotide Synthesis

        11.2.2. Custom Oligonucleotide Synthesis

    11.3. Market Size (US$ Mn) Forecast By Service Type, 2017-2025

        11.3.1. Universal Oligonucleotide Synthesis

        11.3.2. Custom Oligonucleotide Synthesis

    11.4. Market Attractiveness Analysis By Service Type

12. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Application

    12.1. Introduction

        12.1.1. Basis Point Share (BPS) Analysis By Application

        12.1.2. Y-o-Y Growth Projections By Application

    12.2. Historical Market Size (US$ Mn) By Application, 2012-2016

        12.2.1. Research & Development

        12.2.2. Clinical & Commercial

    12.3. Market Size (US$ Mn) Forecast By Application, 2017-2025

        12.3.1. Research & Development

        12.3.2. Clinical & Commercial

    12.4. Market Attractiveness Analysis By Application

13. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By End Users

    13.1. Introduction

        13.1.1. Basis Point Share (BPS) Analysis By End Users

        13.1.2. Y-o-Y Growth Projections By End Users

    13.2. Historical Market Size (US$ Mn) By End Users, 2012-2016

        13.2.1. Biopharmaceutical Companies

        13.2.2. Academic & Research Institutes

        13.2.3. Contract Research Organizations

    13.3. Market Size (US$ Mn) Forecast By End Users, 2017-2025

        13.3.1. Biopharmaceutical Companies

        13.3.2. Academic & Research Institutes

        13.3.3. Contract Research Organizations

    13.4. Market Attractiveness Analysis By End Users

14. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025

    14.1. Market Size and Y-o-Y Growth

    14.2. Absolute $ Opportunity

15. Assumptions and Acronyms Used

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Table 1: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country

Table 2: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 3: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 4: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

Table 5: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country

Table 6: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 7: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 8: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

Table 9: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country

Table 10: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 11: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 12: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

Table 13: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country

Table 14: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 15: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 16: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

Table 17: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country

Table 18: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 19: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 20: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User

Table 21: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, 2017–2025

Table 22: Global Oligonucleotide Synthesis Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region

Table 23: Global Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type

Table 24: Global Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application

Table 25: Global Oligonucleotide Synthesis Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025, By End Users

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 1: Oligonucleotide Synthesis Market Split By Component (2017)

Figure 2: Oligonucleotide Synthesis Market Split By Application (2017)

Figure 3: Oligonucleotide Synthesis Market Split By End Users (2017)

Figure 4: Oligonucleotide Synthesis Market Split By Region (2017)

Figure 5: North America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 6: North America Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 7: U.S. Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 8: U.S. Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 9: Canada Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 10: Canada Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 11: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 12: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 13: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 14: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 15: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment

Figure 16: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment

Figure 17: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment

Figure 18: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment

Figure 19: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment

Figure 20: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment

Figure 21: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment

Figure 22: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment

Figure 23: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment

Figure 24: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment

Figure 25: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type

Figure 26: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Application

Figure 27: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users

Figure 28: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Country

Figure 29: Oligonucleotide Synthesis Market Split By Component (2017)

Figure 30: Oligonucleotide Synthesis Market Split By Application (2017)

Figure 31: Oligonucleotide Synthesis Market Split By End Users (2017)

Figure 32: Oligonucleotide Synthesis Market Split By Region (2017)

Figure 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 35: Brazil Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 36: Brazil Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 37: Mexico Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 38: Mexico Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 39: Rest of Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 40: Rest of Latin America Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 41: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 42: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 43: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 44: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 45: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment

Figure 46: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment

Figure 47: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment

Figure 48: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment

Figure 49: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment

Figure 50: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment

Figure 51: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment

Figure 52: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment

Figure 53: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment

Figure 54: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 55: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type

Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Application

Figure 57: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users

Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Country

Figure 59: Oligonucleotide Synthesis Market Split By Service Type (2017)

Figure 60: Oligonucleotide Synthesis Market Split By Application (2017)

Figure 61: Oligonucleotide Synthesis Market Split By End Users (2017)

Figure 62: Oligonucleotide Synthesis Market Split By Region (2017)

Figure 63: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 64: Europe Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 65: Germany Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 66: Germany Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 67: U.K. Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 68: U.K. Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 69: France Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 70: France Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 71: Italy Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 72: Italy Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 73: Spain Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 74: Spain Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 75: Russia Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 76: Russia Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 77: Rest of Europe Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 78: Rest of Europe Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 79: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 80: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 81: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 82: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 83: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment

Figure 84: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment

Figure 85: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment

Figure 86: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment

Figure 87: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment

Figure 88: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment

Figure 89: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment

Figure 90: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment

Figure 91: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment

Figure 92: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment

Figure 93: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type

Figure 94: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Application

Figure 95: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users

Figure 96: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Country

Figure 97: Oligonucleotide Synthesis Market Split By Component (2017)

Figure 98: Oligonucleotide Synthesis Market Split By Application (2017)

Figure 99: Oligonucleotide Synthesis Market Split By End Users (2017)

Figure 100: Oligonucleotide Synthesis Market Split By Region (2017)

Figure 101: Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 102: Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 103: China Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 104: China Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 105: Japan Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 106: Japan Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 107: India Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 108: India Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 109: ASEAN Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 110: ASEAN Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 111: Australia & New Zealand Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 112: Australia & New Zealand Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 113: Rest of Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 114: Rest of Asia-Pacific Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 115: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 116: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 117: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 118: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 119: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment

Figure 120: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment

Figure 121: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment

Figure 122: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment

Figure 123: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment

Figure 124: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment

Figure 125: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment

Figure 126: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment

Figure 127: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment

Figure 128: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment

Figure 129: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type

Figure 130: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Application

Figure 131: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users

Figure 132: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Country

Figure 133: Oligonucleotide Synthesis Market Split By Component (2017)

Figure 134: Oligonucleotide Synthesis Market Split By Application (2017)

Figure 135: Oligonucleotide Synthesis Market Split By End Users (2017)

Figure 136: Oligonucleotide Synthesis Market Split By Region (2017)

Figure 137: MEA Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 138: MEA Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 139: GCC Countries Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 140: GCC Countries Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 141: South Africa Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 142: South Africa Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 143: Rest of MEA Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 144: Rest of MEA Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 145: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 146: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 147: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016

Figure 148: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025

Figure 149: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment

Figure 150: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment

Figure 151: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment

Figure 152: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment

Figure 153: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment

Figure 154: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment

Figure 155: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment

Figure 156: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment

Figure 157: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment

Figure 158: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment

Figure 159: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type

Figure 160: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Application

Figure 161: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users

Figure 162: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Country

Figure 163: Global Oligonucleotide Synthesis Market Share Analysis (%) By Region, 2017 & 2025

Figure 164: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Region, 2017–2025

Figure 165: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Region, 2017–2025

Figure 166: Global Oligonucleotide Synthesis Market Share Analysis (%) By Service Type, 2017 & 2025

Figure 167: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Service Type, 2017–2025

Figure 168: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Service Type, 2017–2025

Figure 169: Global Oligonucleotide Synthesis Market Share Analysis (%) By Application, 2017 & 2025

Figure 170: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Application, 2016–2025

Figure 171: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Drug Application, 2017–2025

Figure 172: Global Oligonucleotide Synthesis Market Share Analysis (%) By End Users, 2017 & 2025

Figure 173: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By End Users, 2016–2025

Figure 174: Global Oligonucleotide Synthesis Market Attractiveness Analysis By End Users, 2017–2025

Figure 175: Global Oligonucleotide Synthesis Market Value Analysis and Forecast, 2016–2025 (US$ Mn)

Figure 176: Global Oligonucleotide Synthesis Market Value (US$ Mn), 2012–2016

Figure 177: Global Oligonucleotide Synthesis Market Absolute $ Opportunity (US$ Mn), 2016–2025

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate